{
  "content": "49.\nRoy D, Talajic M, Dorian P. et al.Canadian Trial of Atrial Fibrillation Investigators.Amiodarone to prevent recurrence of atrial fibrillation.N Engl J Med.2000;342(13):913-92010738049Google ScholarCrossref\n50.\nLafuente-Lafuente C, Mouly S, Longas-Tejero MA, Mahe I, Bergmann JF.Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials.Arch Intern Med.2006;166(7):719-72816606807Google ScholarCrossref\n51.\nWyse DG, Waldo AL, DiMarco JP. et al.A comparison of rate control and rhythm control in patients with atrial fibrillation.N Engl J Med.2002;347(23):1825-183312466506Google ScholarCrossref\n52.",
  "source": "https://jamanetwork.com/journals/jama/fullarticle/208819",
  "chunk_id": "04076c12-8ea6-42ba-a4eb-a91795c0a153",
  "similarity_score": 0.3707160949707031,
  "query": "atrial fibrillation recurrence rates maintenance therapy amiodarone beta-blockers long-term outcomes rhythm maintenance",
  "rank": 33,
  "title": "Prescribing Amiodarone: An Evidence-Based Review of Clinical Indications",
  "authors": "Patricia Vassallo, Richard G. Trohman",
  "year": "2007",
  "journal": "JAMA",
  "reference": "Vassallo, P., & Trohman, R. G. (2007). Prescribing amiodarone: An evidence-based review of clinical indications. JAMA, 298(11), 1312-1322. https://doi.org/10.1001/jama.298.11.1312",
  "doi": "10.1001/jama.298.11.1312",
  "chunk_index": 142,
  "total_chunks": 177,
  "retrieved_at": "2025-07-24T21:58:13.326319"
}